Advertisement

Deep brain stimulation for tardive syndromes: Systematic review and meta-analysis

  • Antonella Macerollo
    Affiliations
    Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
    Search for articles by this author
  • Günther Deuschl
    Correspondence
    Corresponding author at: Department of Neurology, Universitätsklinikum Schleswig-Holstein, Kiel Campus, Rosalind-Fraenklin str. 10, D-24105 Kiel, Germany.
    Affiliations
    Department of Neurology, Universitätsklinikum Schleswig-Holstein, Kiel Campus, Germany

    Christian-Albrechts Universität, Kiel, Germany
    Search for articles by this author
Published:February 05, 2018DOI:https://doi.org/10.1016/j.jns.2018.02.013

      Abstract

      Among the broad entity of tardive syndromes, tardive dystonia and classical tardive dyskinesia sometimes require advanced treatments like deep brain stimulation of the globus pallidus internum (Gpi-DBS) or the subthalamic nucleus (STN-DBS). This systematic review has analyzed the currently available literature reporting cases with either tardive dystonia or dyskinesia treated with DBS. The key words for the literature search included all tardive syndromes and “deep brain stimulation.” Thirty-four level VI studies and one level II study with 117 patients were included. Level I studies were not identified. Only four of the patients had tardive dyskinesia. All the others had tardive dystonia. The majority had Gpi-DBS (n = 109). Patients had a mean age of 47.4 (± SD 14.7) years. The duration of follow-up was 25.6 months ± 26.2. The Abnormal Involuntary Movement Scale was reported in 51 patients with an improvement of 62 ± 15% and the Burke-Fahn-Marsden scale was reported in 67 cases with an improvement of 76 ± 21%. Reported adverse events were surgery-related in 7 patients, stimulation-induced in 12, and psychiatric in 3 patients. These reports thus suggest favorable effects of DBS and it seems to be relatively safe. DBS can be considered for patients with severe, medication-resistant symptoms. Controlled and randomized studies with blinded outcomes are needed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Soares-Weiser K.F.H.
        Tardive dyskinesia.
        Semin. Neurol. 2007; : 159-169
        • Pasricha P.J.
        • et al.
        Drug insight: from disturbed motility to disordered movement—a review of the clinical benefits and medicolegal risks of metoclopramide.
        Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 138-148
        • Burke R.E.
        • et al.
        Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs.
        Neurology. 1982; 32: 1335-1346
        • Bhidayasiri R.
        • Boonyawairoj S.
        Spectrum of tardive syndromes: clinical recognition and management.
        Postgrad. Med. J. 2011; 87: 132-141
        • Lane R.D.
        • et al.
        Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale.
        J. Nerv. Ment. Dis. 1985; 173: 353-357
        • Burke R.E.
        • et al.
        Validity and reliability of a rating scale for the primary torsion dystonias.
        Neurology. 1985; 35: 73-77
        • Chouinard G.
        • Margolese H.C.
        Manual for the extrapyramidal symptom rating scale (ESRS).
        Schizophr. Res. 2005; 76: 247-265
      1. Standaert D.G. Galanter J.M. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. Lippincott Williams & Wilkins, 2008
        • Waln O.
        • Jankovic J.
        An update on tardive dyskinesia: from phenomenology to treatment.
        Tremor Other Hyperkinet Mov (N Y). 2013; : 3
        • Casey D.E.
        Tardive dyskinesia: pathophysiology and animal models.
        J Clin Psychiatry. 2000; 61: 5-9
        • Corson P.W.
        • et al.
        Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics.
        Am. J. Psychiatry. 1999; 156: 1200-1204
        • Ogawa T.
        • et al.
        Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
        Clin. Ther. 1984; (7 Spec No): 1-17
        • Jankovic J.
        • Clarence-Smith K.
        Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
        Expert. Rev. Neurother. 2011; 11: 1509-1523
        • Thaker G.K.
        • et al.
        Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
        Am. J. Psychiatry. 1990; 147: 445-451
        • van Harten P.N.
        • Hovestadt A.
        Botulinum toxin as a treatment for tardive dyskinesia.
        Mov. Disord. 2006; 21: 1276-1277
        • Schrader C.
        • et al.
        Unilateral deep brain stimulation of the internal globus pallidus alleviates tardive dyskinesia.
        Mov. Disord. 2004; 19: 583-585
        • Eltahawy H.A.
        • et al.
        Bilateral globus pallidus internus deep brain stimulation in tardive dyskinesia: a case report.
        Mov. Disord. 2004; 19: 969-972
        • Kefalopoulou Z.
        • et al.
        A double-blind study on a patient with tardive dyskinesia treated with pallidal deep brain stimulation.
        Acta Neurol. Scand. 2009; 119: 269-273
        • Spindler M.A.
        • et al.
        Globus pallidus interna deep brain stimulation for tardive dyskinesia: case report and review of the literature.
        Parkinsonism Relat. Disord. 2013; 19: 141-147
        • Trottenberg T.
        • et al.
        Pallidal and thalamic neurostimulation in severe tardive dystonia.
        J. Neurol. Neurosurg. Psychiatry. 2001; 70: 557-559
        • Johnsen M.
        • Wester K.
        Full remission of tardive dyskinesia following general anaesthesia.
        J. Neurol. 2002; 249: 622-625
        • Yianni J.
        • et al.
        Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit.
        Mov. Disord. 2003; 18: 436-442
        • Krause M.
        • et al.
        Pallidal stimulation for dystonia.
        Neurosurgery. 2004; 55 (discussion 1368-70): 1361-1368
        • Franzini A.
        • et al.
        Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia. Report of two cases.
        J. Neurosurg. 2005; 102: 721-725
        • Halbig T.D.
        • et al.
        Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life.
        J. Neurol. Neurosurg. Psychiatry. 2005; 76: 1713-1716
        • Trottenberg T.
        • et al.
        Treatment of severe tardive dystonia with pallidal deep brain stimulation.
        Neurology. 2005; 64: 344-346
        • Starr P.A.
        • et al.
        Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes.
        J. Neurosurg. 2006; 104: 488-501
        • Zhang J.G.
        • Zhang K.
        • Wang Z.C.
        Deep brain stimulation in the treatment of tardive dystonia.
        Chin. Med. J. 2006; 119: 789-792
        • Cohen O.S.
        • Hassin-Baer S.
        • Spiegelmann R.
        Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia.
        Parkinsonism Relat. Disord. 2007; 13: 541-544
        • Damier P.
        • et al.
        Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
        Arch. Gen. Psychiatry. 2007; 64: 170-176
        • Egidi M.
        • et al.
        A survey of Italian cases of dystonia treated by deep brain stimulation.
        J. Neurosurg. Sci. 2007; 51: 153-158
        • Kosel M.
        • et al.
        Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression.
        J. Psychiatr. Res. 2007; 41: 801-803
        • Magarinos-Ascone C.M.
        • et al.
        Deep brain stimulation in the globus pallidus to treat dystonia: electrophysiological characteristics and 2 years' follow-up in 10 patients.
        Neuroscience. 2008; 152: 558-571
        • Pretto T.E.
        • et al.
        A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes.
        J. Neurosurg. 2008; 109: 405-409
        • Sako W.
        • et al.
        Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia.
        Mov. Disord. 2008; 23: 1929-1931
        • Gruber D.
        • et al.
        Long-term effects of pallidal deep brain stimulation in tardive dystonia.
        Neurology. 2009; 73: 53-58
        • Katsakiori P.F.
        • et al.
        Deep brain stimulation for secondary dystonia: results in 8 patients.
        Acta Neurochir. 2009; 151 (discussion 478): 473-478
        • Capelle H.H.
        • et al.
        Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis.
        Mov. Disord. 2010; 25: 1477-1481
        • Chang E.F.
        • et al.
        Long-term benefit sustained after bilateral pallidal deep brain stimulation in patients with refractory tardive dystonia.
        Stereotact. Funct. Neurosurg. 2010; 88: 304-310
        • Kim J.P.
        • Chang W.S.
        • Chang J.W.
        Treatment of secondary dystonia with a combined stereotactic procedure: long-term surgical outcomes.
        Acta Neurochir. 2011; 153 (discussion 2328): 2319-2327
        • Boulogne S.
        • et al.
        Relapse of tardive dystonia after globus pallidus deep-brain stimulation discontinuation.
        J. Neurol. 2014; 261: 1636-1637
        • Puri M.
        • Albassam A.
        • Silver B.
        Deep brain stimulation in the treatment of tardive dyskinesia.
        Psychiatr. Ann. 2014; 44: 123-125
        • Trinh B.
        • et al.
        Dramatic improvement of truncal tardive dystonia following globus pallidus pars interna deep brain stimulation.
        J. Clin. Neurosci. 2014; 21: 515-517
        • Woo P.Y.
        • et al.
        Pallidal deep brain stimulation: an effective treatment in Chinese patients with tardive dystonia.
        Hong Kong Med J. 2014; 20: 455-459
        • Shaikh A.G.
        • et al.
        Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation.
        Parkinsonism Relat. Disord. 2015; 21: 116-119
        • Meng D.W.
        • et al.
        Long-term effects of subthalamic nucleus deep brain stimulation in tardive dystonia.
        Chin. Med. J. 2016; 129: 1257-1258
        • Pouclet-Courtemanche H.
        • et al.
        Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.
        Neurology. 2016; 86: 651-659
        • Sobstyl M.
        • et al.
        Deep brain stimulation of the internal globus pallidus for disabling haloperidol-induced tardive dystonia. Report of two cases.
        Neurol. Neurochir. Pol. 2016; 50: 258-261
        • Deng Z.D.
        • et al.
        Long-term follow-up of bilateral subthalamic deep brain stimulation for refractory tardive dystonia.
        Parkinsonism Relat. Disord. 2017; 41: 58-65
        • Kovacs N.
        • et al.
        Status dystonicus in tardive dystonia successfully treated by bilateral deep brain stimulation.
        Clin. Neurol. Neurosurg. 2011; 113: 808-809